Morgan Stanley »

Evoke Pharma shares owned by Morgan Stanley

Quarter-by-quarter ownership of Evoke Pharma (EVOK) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Evoke Pharma

Tip: Access up to 7 years of quarterly data

All positions including Evoke Pharma held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evoke Pharma by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $166 64 2.59
2024-12-31 $137 31 4.42
2024-09-30 $148 31 4.77

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Evoke Pharma

Nantahala Capital Management
Bleichroeder
National Wealth Management Group
DRW Holdings
Vanguard Group
Two Sigma Securities
Advisor Group Holdings
Northwestern Mutual Wealth Management Company
Royal Bank of Canada
BlackRock
SBI Securities
Morgan Stanley
Tower Research Capital
Goss Wealth Management

View all funds holding Evoke Pharma